Clinical Trial Update: Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating concomitant administration of Novel Oral Polio Type 2 vaccine with a bivalent OPV has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Bivalent Oral Polio Vaccine
• Novel Oral Polio Type 2 vaccine

Snippet

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 3 | Status: WITHDRAWN